Hepatic Insufficiency  >>  Vanihep (vaniprevir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vanihep (vaniprevir) / Merck (MSD)
NCT01010906: A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)

Completed
1
60
NA
Vaniprevir 300 mg, MK-7009, Vaniprevir 200 mg
Merck Sharp & Dohme LLC
Hepatitis C
06/10
06/10

Download Options